RNS Number:1911D
Cambridge Antibody Tech Group PLC
18 May 2006





Page 1 of 1

FOR IMMEDIATE RELEASE


Thursday 18th May 2006

For further information contact:   

          
Cambridge Antibody Technology           Hogarth (Europe)
Tel: +44 (0) 1223 471 471               Tel: +44 (0) 20 7357 9477
Peter Chambre, Chief Executive Officer  Melanie Toyne-Sewell
John Aston, Chief Financial Officer     Andrew Jaques
Rowena Gardner, Director of Corporate
Communications

                                         BMC Communications/The Trout Group(USA)
                                         Tel: 001 212 477 9007                                         
                                         Brad Miles, ext 17 (media)
                                         Brandon Lewis, ext 15 (investors)
                                         

                            NOTIFICATION OF RESULTS

Cambridge, UK... Cambridge Antibody Technology Group plc ("CAT") (LSE: CAT;
NASDAQ: CATG) will be announcing its interim results at 7am BST on Monday 22 May
2006. Following the recent announcement of the recommended cash offer by
AstraZeneca International plc for CAT, the Company will be issuing a shortened
interims statement reflecting the Company's present position, but will not be
holding a group meeting or conference call for analysts on the day.


                                    - ENDS -




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
NORFVLFFQEBFBBB
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Catco Reinsurance Opport... Charts.
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Catco Reinsurance Opport... Charts.